Table 3.
Crude | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|
β (95% CI) | p | β (95% CI) | p | β (95% CI) | p | |
CDR 0.5 | 1.64 (−3.71; 0.42) | 0.119 | −1.18 (−3.16; 0.80) | 0.242 | −1.12 (−3.07; 0.83) | 0.258 |
CDR 1 | −2.60 (−5.07; 0.14) | 0.039 | −1.19 (−3.60; 1.22) | 0.332 | −1.04 (−3.40; 1.32) | 0.387 |
CDR 2 | −3.71 (−6.00; −1.42) | 0.002 | −2.63 (−4.84; −0.42) | 0.019 | −2.24 (−4.48; −0.06) | 0.044 |
CDR 3 | −5.21 (−6.48; −3.94) | <0.001 | −3.95 (−5.22; −2.68) | <0.0001 | −3.16 (−4.52; −1.85) | <0.0001 |
Reference: CDR 0 (without dementia).
CDR 0.5 (questionable dementia), CDR 1 (mild dementia), CDR 2 (moderate dementia), and CDR 3 (severe dementia).
Model 1: linear regression model, adjusted for age, sex, race, and education.
Model 2: linear regression model, adjusted for age, sex, race, education, hypertension, diabetes, coronary artery disease, heart failure, dyslipidemia, physical inactivity, and alcohol use.